Skip to main content
Annovis Bio, Inc. logo

Annovis Bio, Inc. — Investor Relations & Filings

Ticker · ANVS ISIN · US03615A1088 LEI · 549300IFBVI51FN3NJ32 US Professional, scientific and technical activities
Open in API
Filings indexed 290 across all filing types
Latest filing 2021-04-19 Proxy Solicitation & In…
Country US United States of America
Listing US ANVS

About Annovis Bio, Inc.

https://www.annovisbio.com/

Annovis Bio, Inc. is a clinical-stage drug platform company that develops therapies for neurodegenerative diseases. The company's primary focus is on conditions such as Alzheimer's disease (AD) and Parkinson's disease (PD). Its lead product candidate, buntanetap, is a translational inhibitor designed to halt the death of nerve cells by targeting the synthesis of multiple neurotoxic proteins. The company's therapeutic approach aims to restore nerve cell function, with the goal of improving cognitive and motor abilities in patients suffering from neurodegeneration.

Recent filings

Filing Released Lang Actions
DEF 14A
Proxy Solicitation & Information Statement
2021-04-19 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the appointment of a new director, Reid S. McCarthy, to the Board of Directors and his qualifications. This fits the category of announcements related to changes in the company's board or senior management. There is no financial data or report attached, and the document is not an earnings release or annual report. Therefore, the appropriate classification is Board/Management Information (MANG). The document length and detail support a high confidence level.
2021-04-15 English
FORM 8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated March 23, 2021. It announces a Regulation FD Disclosure regarding a Q1 Investor Summit presentation by the CEO and CFO, including a webcast and attached presentation materials (Exhibit 99.1). The document explicitly states that the information is furnished pursuant to Item 7.01 of Form 8-K and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act. The content is primarily an announcement of an investor presentation event and the availability of presentation materials, not the presentation itself or a detailed financial report. The document length is 5821 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as an Investor Presentation (IP) announcement within a Form 8-K filing, but since the document itself contains the presentation materials as an exhibit, it aligns with the Investor Presentation category rather than a pure announcement (RPA).
2021-03-23 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes an entry into a material definitive agreement and changes in the board of directors and committee appointments. There are no financial statements or detailed financial performance data, so it is not an Annual Report (10-K) or Interim Report (IR). The document specifically announces changes in the company's board and management, which fits the Board/Management Information category (MANG). The length is about 5,023 characters, which is sufficient for a substantive announcement rather than a brief notice. Therefore, the correct classification is MANG with high confidence.
2021-03-15 English
10-K
Annual Report FY 2020
2021-03-03 English
Regulatory Filings 2021
Regulatory Filings
2021-02-12 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.